Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody

scientific article published on 26 March 2009

Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2567.2009.03076.X
P698PubMed publication ID19740335

P50authorDaniele NoëlQ63405998
Christian JorgensenQ64004959
P2093author name stringPierre Corbeau
Thierry Vincent
Sylvie Fabre
Caroline Desmetz
Jacques Clot
Pierre Portalès
Brigitte Réant
P2860cites workTNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expressionQ22010551
Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpuraQ33375482
Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpressionQ33835337
Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritisQ34129985
Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysisQ35014330
The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targetsQ35111838
C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritisQ35126948
Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritisQ35554196
Rituximab: in rheumatoid arthritisQ36951960
Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis modelQ37383845
TNF-alpha-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytesQ39077325
Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokinesQ39112921
Acquisition of HIV type 1 resistance by beta-chemokine-producing CD4+ T cellsQ39202267
Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection.Q39269743
Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytesQ39343141
Endocytosis and recycling of the HIV coreceptor CCR5Q39461957
Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytesQ40158567
Genomic organization and transcriptional regulation of the RANTES chemokine geneQ41532603
Chemokine production by human chondrocytesQ42477798
Interleukin-2 up-regulates expression of the human immunodeficiency virus fusion coreceptor CCR5 by CD4+ lymphocytes in vivoQ45743773
CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.Q45743774
Regulation of CCR5 expression and MIP-1α production in CD4+ T cells from patients with rheumatoid arthritisQ47969482
The delta32 deletion of CCR5 receptor in rheumatoid arthritisQ47973433
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.Q51978495
CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis.Q54020149
Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritisQ57012210
Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 miceQ57019206
CC chemokine receptor 5 polymorphism in rheumatoid arthritisQ63728135
RANTES and chemokines in rheumatoid arthritisQ71623497
Expression of the chemokine superfamily in rheumatoid arthritisQ71645876
Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cellsQ71708739
Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokinesQ72072827
The chemokines CCL5, CCL2 and CXCL12 play significant roles in the migration of Th1 cells into rheumatoid synovial tissueQ73006434
CXCR3 and CCR5 ligands in rheumatoid arthritis synoviumQ73352970
RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritisQ74002483
Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult bloodQ74561784
T cell activation in rheumatoid synovium is B cell dependentQ74601890
RANTES expression and contribution to monocyte chemotaxis in arthritisQ77359406
Selective lymphocyte chemokine receptor expression in the rheumatoid jointQ77406819
Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritisQ77738063
Association of rheumatoid arthritis with a functional chemokine receptor, CCR5Q77738649
Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexateQ78178323
The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 densityQ79440686
The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5Q80493657
P433issue1 Suppl
P921main subjectrheumatoid arthritisQ187255
P304page(s)e738-45
P577publication date2009-03-26
P1433published inImmunologyQ15754984
P1476titlePeripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody
P478volume128

Reverse relations

cites work (P2860)
Q35804294Chemokine receptors expression on peripheral CD4-lymphocytes in rheumatoid arthritis: Coexpression of CCR7 and CD95 is associated with disease activity.
Q50872769Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis.
Q90642824Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis
Q38647749Successes and failures of chemokine-pathway targeting in rheumatoid arthritis

Search more.